Unknown

Dataset Information

0

Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies.


ABSTRACT: Chimeric antigen receptor T cells (CAR T Cells) have led to dramatic improvements in the survival of cancer patients, most notably those with hematologic malignancies. Early phase clinical trials in patients with solid tumors have demonstrated them to be feasible, but unfortunately has yielded limited efficacy for various cancer types. In this article we will review the background on CAR T cells for the treatment of solid tumors, focusing on the unique obstacles that solid tumors present for the development of adoptive T cell therapy, and the novel approaches currently under development to overcome these hurdles.

SUBMITTER: Heyman B 

PROVIDER: S-EPMC6407020 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies.

Heyman Benjamin B   Yang Yiping Y  

Cancers 20190206 2


Chimeric antigen receptor T cells (CAR T Cells) have led to dramatic improvements in the survival of cancer patients, most notably those with hematologic malignancies. Early phase clinical trials in patients with solid tumors have demonstrated them to be feasible, but unfortunately has yielded limited efficacy for various cancer types. In this article we will review the background on CAR T cells for the treatment of solid tumors, focusing on the unique obstacles that solid tumors present for the  ...[more]

Similar Datasets

| S-EPMC6790340 | biostudies-literature
| S-EPMC4849432 | biostudies-literature
| S-EPMC8445151 | biostudies-literature
| S-EPMC5372296 | biostudies-literature
| S-EPMC10362352 | biostudies-literature
| S-EPMC5767005 | biostudies-literature
| S-EPMC9847472 | biostudies-literature
| S-EPMC7226583 | biostudies-literature
| S-EPMC7907037 | biostudies-literature
| S-EPMC10334497 | biostudies-literature